APC and colorectal cancer: For instance, by applying gene-editing technology, researchers have developed APC, TP53, KRAS, SMAD4 and/or PIK3CA mutated cancer driver pathway colorectal cancer (CRC) organoids, which were able to generate micrometastases when implanted into the mice.